The FINISH-3 Trial: A Phase 3, International, Randomized, Single-Blind, Controlled Trial of Topical Fibrocaps in Intraoperative Surgical Hemostasis

This Phase 3, international, randomized, single-blind, controlled trial (FINISH-3) compared the efficacy and safety of Fibrocaps, a ready-to-use, dry-powder fibrin sealant containing human plasma-derived thrombin and fibrinogen, vs. gelatin sponge alone for use as a hemostat for surgical bleeding in 4 indications (spinal, hepatic, vascular, soft tissue dissection).

Source: Journal of the American College of Surgeons - October 13, 2014 Category: Surgery Authors: Grant V. Bochicchio, Navyash Gupta, Robert Porte, Kenneth L. Renkens, Piet Pattyn, Baki Topal, Roberto Ivan Troisi, William Muir, Ian Chetter, Daniel L. Gillen, Linda A. Zuckerman, Paul A. Frohna Tags: Original Scientific Article Source Type: research